CA2283299A1 - 186 nouvelles proteines secretees - Google Patents

186 nouvelles proteines secretees Download PDF

Info

Publication number
CA2283299A1
CA2283299A1 CA 2283299 CA2283299A CA2283299A1 CA 2283299 A1 CA2283299 A1 CA 2283299A1 CA 2283299 CA2283299 CA 2283299 CA 2283299 A CA2283299 A CA 2283299A CA 2283299 A1 CA2283299 A1 CA 2283299A1
Authority
CA
Canada
Prior art keywords
gene
tissues
polypeptides
useful
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2283299
Other languages
English (en)
Inventor
Steven M. Ruben
Craig A. Rosen
Carrie L. Fischer
Daniel R. Soppet
Kenneth C. Carter
Daniel P. Bednarik
Gregory A. Endress
Guo-Liang Yu
Jian Ni
Ping Feng
Paul E. Young
John M. Greene
Ann M. Ferrie
Roxanne Duan
Jing-Shan Hu
Kimberly A. Florence
Henrik S. Olsen
Reinhard Ebner
Laurie A. Brewer
Paul A. Moore
Yanggu Shi
David W. Lafleur
Yi Li
Zhizhen Zeng
Hla Kyaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences, Inc.
Steven M. Ruben
Craig A. Rosen
Carrie L. Fischer
Daniel R. Soppet
Kenneth C. Carter
Daniel P. Bednarik
Gregory A. Endress
Guo-Liang Yu
Jian Ni
Ping Feng
Paul E. Young
John M. Greene
Ann M. Ferrie
Roxanne Duan
Jing-Shan Hu
Kimberly A. Florence
Henrik S. Olsen
Reinhard Ebner
Laurie A. Brewer
Paul A. Moore
Yanggu Shi
David W. Lafleur
Yi Li
Zhizhen Zeng
Hla Kyaw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences, Inc., Steven M. Ruben, Craig A. Rosen, Carrie L. Fischer, Daniel R. Soppet, Kenneth C. Carter, Daniel P. Bednarik, Gregory A. Endress, Guo-Liang Yu, Jian Ni, Ping Feng, Paul E. Young, John M. Greene, Ann M. Ferrie, Roxanne Duan, Jing-Shan Hu, Kimberly A. Florence, Henrik S. Olsen, Reinhard Ebner, Laurie A. Brewer, Paul A. Moore, Yanggu Shi, David W. Lafleur, Yi Li, Zhizhen Zeng, Hla Kyaw filed Critical Human Genome Sciences, Inc.
Publication of CA2283299A1 publication Critical patent/CA2283299A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2283299 1997-03-07 1998-03-06 186 nouvelles proteines secretees Abandoned CA2283299A1 (fr)

Applications Claiming Priority (198)

Application Number Priority Date Filing Date Title
US4016297P 1997-03-07 1997-03-07
US4016197P 1997-03-07 1997-03-07
US4033497P 1997-03-07 1997-03-07
US3862197P 1997-03-07 1997-03-07
US4062697P 1997-03-07 1997-03-07
US4016397P 1997-03-07 1997-03-07
US4033397P 1997-03-07 1997-03-07
US4033697P 1997-03-07 1997-03-07
US60/040,626 1997-03-07
US60/040,336 1997-03-07
US60/040,333 1997-03-07
US60/040,161 1997-03-07
US60/040,163 1997-03-07
US60/040,334 1997-03-07
US60/038,621 1997-03-07
US60/040,162 1997-03-07
US4356997P 1997-04-11 1997-04-11
US4331497P 1997-04-11 1997-04-11
US4357697P 1997-04-11 1997-04-11
US4367497P 1997-04-11 1997-04-11
US4357897P 1997-04-11 1997-04-11
US4331297P 1997-04-11 1997-04-11
US4356897P 1997-04-11 1997-04-11
US4367297P 1997-04-11 1997-04-11
US4358097P 1997-04-11 1997-04-11
US4366997P 1997-04-11 1997-04-11
US4331397P 1997-04-11 1997-04-11
US4331197P 1997-04-11 1997-04-11
US4367197P 1997-04-11 1997-04-11
US4367097P 1997-04-11 1997-04-11
US60/043,674 1997-04-11
US60/043,314 1997-04-11
US60/043,312 1997-04-11
US60/043,576 1997-04-11
US60/043,669 1997-04-11
US60/043,580 1997-04-11
US60/043,569 1997-04-11
US60/043,671 1997-04-11
US60/043,313 1997-04-11
US60/043,578 1997-04-11
US60/043,670 1997-04-11
US60/043,568 1997-04-11
US60/043,672 1997-04-11
US60/043,311 1997-04-11
US4758697P 1997-05-23 1997-05-23
US4760197P 1997-05-23 1997-05-23
US4758997P 1997-05-23 1997-05-23
US4759697P 1997-05-23 1997-05-23
US4750097P 1997-05-23 1997-05-23
US4761897P 1997-05-23 1997-05-23
US4761597P 1997-05-23 1997-05-23
US4758497P 1997-05-23 1997-05-23
US4759497P 1997-05-23 1997-05-23
US4750297P 1997-05-23 1997-05-23
US4763297P 1997-05-23 1997-05-23
US4758197P 1997-05-23 1997-05-23
US4761297P 1997-05-23 1997-05-23
US4758397P 1997-05-23 1997-05-23
US4760097P 1997-05-23 1997-05-23
US4750397P 1997-05-23 1997-05-23
US4761397P 1997-05-23 1997-05-23
US4759297P 1997-05-23 1997-05-23
US4761497P 1997-05-23 1997-05-23
US4759397P 1997-05-23 1997-05-23
US4750197P 1997-05-23 1997-05-23
US4759997P 1997-05-23 1997-05-23
US4758297P 1997-05-23 1997-05-23
US4761797P 1997-05-23 1997-05-23
US4749297P 1997-05-23 1997-05-23
US4759897P 1997-05-23 1997-05-23
US4763397P 1997-05-23 1997-05-23
US4758897P 1997-05-23 1997-05-23
US4759797P 1997-05-23 1997-05-23
US4759597P 1997-05-23 1997-05-23
US4758597P 1997-05-23 1997-05-23
US4758797P 1997-05-23 1997-05-23
US4759097P 1997-05-23 1997-05-23
US60/047,500 1997-05-23
US60/047,595 1997-05-23
US60/047,594 1997-05-23
US60/047,586 1997-05-23
US60/047,492 1997-05-23
US60/047,600 1997-05-23
US60/047,592 1997-05-23
US60/047,617 1997-05-23
US60/047,612 1997-05-23
US60/047,618 1997-05-23
US60/047,582 1997-05-23
US60/047,589 1997-05-23
US60/047,502 1997-05-23
US60/047,581 1997-05-23
US60/047,633 1997-05-23
US60/047,583 1997-05-23
US60/047,598 1997-05-23
US60/047,588 1997-05-23
US60/047,613 1997-05-23
US60/047,501 1997-05-23
US60/047,599 1997-05-23
US60/047,503 1997-05-23
US60/047,632 1997-05-23
US60/047,585 1997-05-23
US60/047,597 1997-05-23
US60/047,614 1997-05-23
US60/047,601 1997-05-23
US60/047,615 1997-05-23
US60/047,584 1997-05-23
US60/047,596 1997-05-23
US60/047,590 1997-05-23
US60/047,587 1997-05-23
US60/047,593 1997-05-23
US4897497P 1997-06-06 1997-06-06
US4896497P 1997-06-06 1997-06-06
US60/048,974 1997-06-06
US60/048,964 1997-06-06
US4961097P 1997-06-13 1997-06-13
US60/049,610 1997-06-13
US5192697P 1997-07-08 1997-07-08
US60/051,926 1997-07-08
US5287497P 1997-07-16 1997-07-16
US60/052,874 1997-07-16
US5572497P 1997-08-18 1997-08-18
US60/055,724 1997-08-18
US5687597P 1997-08-22 1997-08-22
US5688797P 1997-08-22 1997-08-22
US5688997P 1997-08-22 1997-08-22
US5690897P 1997-08-22 1997-08-22
US5686297P 1997-08-22 1997-08-22
US5686497P 1997-08-22 1997-08-22
US5687297P 1997-08-22 1997-08-22
US5689497P 1997-08-22 1997-08-22
US5691097P 1997-08-22 1997-08-22
US5666297P 1997-08-22 1997-08-22
US5689297P 1997-08-22 1997-08-22
US5688197P 1997-08-22 1997-08-22
US5688097P 1997-08-22 1997-08-22
US5687797P 1997-08-22 1997-08-22
US5688497P 1997-08-22 1997-08-22
US5690997P 1997-08-22 1997-08-22
US5688697P 1997-08-22 1997-08-22
US5691197P 1997-08-22 1997-08-22
US5690397P 1997-08-22 1997-08-22
US5687897P 1997-08-22 1997-08-22
US5684597P 1997-08-22 1997-08-22
US5666497P 1997-08-22 1997-08-22
US5663097P 1997-08-22 1997-08-22
US5688897P 1997-08-22 1997-08-22
US5687497P 1997-08-22 1997-08-22
US5663697P 1997-08-22 1997-08-22
US5689397P 1997-08-22 1997-08-22
US5663197P 1997-08-22 1997-08-22
US5687697P 1997-08-22 1997-08-22
US5663297P 1997-08-22 1997-08-22
US5688297P 1997-08-22 1997-08-22
US5687997P 1997-08-22 1997-08-22
US5663797P 1997-08-22 1997-08-22
US60/056,664 1997-08-22
US60/056,892 1997-08-22
US60/056,888 1997-08-22
US60/056,910 1997-08-22
US60/056,874 1997-08-22
US60/056,911 1997-08-22
US60/056,881 1997-08-22
US60/056,879 1997-08-22
US60/056,909 1997-08-22
US60/056,875 1997-08-22
US60/056,887 1997-08-22
US60/056,889 1997-08-22
US60/056,632 1997-08-22
US60/056,862 1997-08-22
US60/056,637 1997-08-22
US60/056,882 1997-08-22
US60/056,877 1997-08-22
US60/056,864 1997-08-22
US60/056,876 1997-08-22
US60/056,894 1997-08-22
US60/056,631 1997-08-22
US60/056,908 1997-08-22
US60/056,880 1997-08-22
US60/056,893 1997-08-22
US60/056,903 1997-08-22
US60/056,636 1997-08-22
US60/056,886 1997-08-22
US60/056,630 1997-08-22
US60/056,884 1997-08-22
US60/056,845 1997-08-22
US60/056,662 1997-08-22
US60/056,872 1997-08-22
US5766997P 1997-09-05 1997-09-05
US5765097P 1997-09-05 1997-09-05
US5776197P 1997-09-05 1997-09-05
US60/057,669 1997-09-05
US60/057,650 1997-09-05
US60/057,761 1997-09-05
US5878597P 1997-09-12 1997-09-12
US60/058,785 1997-09-12
US6106097P 1997-10-02 1997-10-02
US60/061,060 1997-10-02
US60/056,878 1997-11-17

Publications (1)

Publication Number Publication Date
CA2283299A1 true CA2283299A1 (fr) 1998-09-11

Family

ID=27587107

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2283299 Abandoned CA2283299A1 (fr) 1997-03-07 1998-03-06 186 nouvelles proteines secretees

Country Status (2)

Country Link
CA (1) CA2283299A1 (fr)
WO (1) WO1998039448A2 (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274312B1 (en) 1996-12-11 2001-08-14 Schering Corporation Intracellular regulatory molecules; related reagents
US6444440B1 (en) 1997-03-07 2002-09-03 Human Genome Sciences, Inc. Vanilloid receptor-2
US6420526B1 (en) 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JPH11103867A (ja) * 1997-05-07 1999-04-20 Smithkline Beecham Corp Ｅｐｏ一次応答遺伝子１、ｅｐｒｇ１
WO1999000408A2 (fr) * 1997-05-13 1999-01-07 Incyte Pharmaceuticals, Inc. Nouvelle proteine transmembranaire humaine
US20020198149A1 (en) 1997-06-16 2002-12-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7074895B2 (en) 1997-08-21 2006-07-11 Quark Biotech, Inc. Sequences characteristic of hypoxia-regulated gene transcription
WO1999018126A1 (fr) 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
WO1999033963A1 (fr) * 1997-12-31 1999-07-08 Chiron Corporation Gene regule par cancer metastatique
US7151161B1 (en) 1998-01-13 2006-12-19 Oscient Pharmaceuticals Corporation Human genes of chromosome 11q13.3
US7045333B1 (en) 1998-01-16 2006-05-16 Incyte Corporation Human protease molecules
WO1999037765A1 (fr) * 1998-01-27 1999-07-29 Smithkline Beecham Plc Homologues du recepteur humain des vanilloides
JPH11332571A (ja) * 1998-05-29 1999-12-07 Taisho Pharmaceut Co Ltd 新規遺伝子とそれにコードされる蛋白質
CA2328895A1 (fr) * 1998-06-02 1999-12-09 Genentech, Inc. Proteines membranaires et acides nucleiques codant ces proteines
CA2337904A1 (fr) * 1998-08-03 2000-02-17 Novartis Ag Nouveaux genes de regulation de l'hematopoiese
US6451558B1 (en) 1998-08-03 2002-09-17 Novartis Ag Genes in the control of hematopoiesis
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US6906178B2 (en) 1998-08-11 2005-06-14 Human Genome Sciences, Inc. Vanilloid receptor-2
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1115733A4 (fr) * 1998-08-27 2003-01-22 Quark Biotech Inc Sequences caracteristiques de la transcription genique regulee par l'hypoxemie
US20030163845A1 (en) 1998-09-02 2003-08-28 Pradip Mukerji Elongase genes and uses thereof
US6677145B2 (en) 1998-09-02 2004-01-13 Abbott Laboratories Elongase genes and uses thereof
JP4486187B2 (ja) 1998-10-27 2010-06-23 武田薬品工業株式会社 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
AU2148000A (en) * 1998-11-13 2000-06-05 Millennium Pharmaceuticals, Inc. Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
US7063951B1 (en) 1998-11-13 2006-06-20 Millennium Pharmaceuticals, Inc. Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
DE69934246T2 (de) * 1998-12-04 2007-05-03 Glycozym Aps UDP-N-ACETYLGLUCOSAMINE:GALACTOSE-ß1,3-N-ACETYLGALACTOSAMINE-a-R/N-ACETYLGLUCOSAMINE-ß1,3-N-ACETYLGALACTOSAMINE-a-R(G.cNActo GalNAc) ß1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2/4GnT
CA2356987A1 (fr) * 1998-12-23 2000-06-29 Corixa Corporation Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
AU2757500A (en) * 1999-02-10 2000-08-29 Human Genome Sciences, Inc. 33 human secreted proteins
CA2364650A1 (fr) * 1999-03-12 2000-09-21 Craig A. Rosen Proteines humaines secretees (50)
JP2002539841A (ja) * 1999-03-26 2002-11-26 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ５０個のヒト分泌タンパク質
EP1173477A4 (fr) * 1999-04-09 2003-02-26 Human Genome Sciences Inc 49 proteines humaines secretees
DE19919225A1 (de) * 1999-04-28 2000-11-16 Boehringer Ingelheim Int Tumorassoziiertes Antigen
CN1244584A (zh) * 1999-05-14 2000-02-16 北京医科大学 具有免疫细胞趋化和造血刺激活性的趋化因子
CA2374341A1 (fr) * 1999-05-20 2000-11-30 Takeda Chemical Industries, Ltd. Nouveau polypeptide
ATE478145T1 (de) * 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
EP1185543A4 (fr) * 1999-06-11 2003-09-03 Human Genome Sciences Inc 50 proteines humaines secretees
AU6181200A (en) * 1999-07-29 2001-02-19 Helix Research Institute Stomach cancer-associated gene
CA2376404A1 (fr) * 1999-08-19 2001-03-01 Toshio Miyata Proteine meg-1
US7070970B2 (en) 1999-08-23 2006-07-04 Abbott Laboratories Elongase genes and uses thereof
PT1083224E (pt) 1999-09-02 2007-03-30 Leadd Bv Proteína associada a apoptina
FR2801056B1 (fr) 1999-11-12 2003-03-28 Commissariat Energie Atomique Proteine presente a la surface des cellules souches hematopoietiques de la lignee lymphoide et des cellules nk, et ses applications
IL150134A0 (en) 1999-12-10 2002-12-01 Leadd Bv Apoptin-associating protein
EP1111045A3 (fr) * 1999-12-10 2001-09-19 Leadd B.V. Protéine associée à l'apoptine
AU1889101A (en) 1999-12-17 2001-06-25 Takeda Chemical Industries Ltd. Process for producing kiss-1 peptide
US6511834B1 (en) 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
EP1287129A1 (fr) * 2000-05-19 2003-03-05 F.Hoffmann-La Roche Ag Procede permettant de determiner le potentiel tumoricide d'un prelevement a l'aide d'un acide nucleique qui subit une regulation negative dans les cellules tumorales humaines
AU2001280987A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of head and neck cancer
CA2421056A1 (fr) * 2000-09-01 2002-03-28 Genentech, Inc. Polypeptide servant de marqueur diagnostique de presence de tumeurs du colon
AU2002219046A1 (en) * 2000-10-24 2002-05-06 Bayer Aktiengesellschaft Regulation of human ceruloplasmin-like protein
US20020072488A1 (en) * 2000-12-12 2002-06-13 Merkulov Gennady V. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
FR2841261B1 (fr) * 2002-06-25 2004-08-27 Univ Pasteur Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire
KR20050090420A (ko) 2002-12-26 2005-09-13 다케다 야쿠힌 고교 가부시키가이샤 메타스틴 유도체 및 이의 용도
US7754220B2 (en) 2003-03-12 2010-07-13 Takeda Pharmaceutical Company Limited Methods of inhibiting secretion of follicle-stimulating hormone and testosterone
EP1613649A2 (fr) * 2003-04-04 2006-01-11 Ingenium Pharmaceuticals AG Genes de proteines de type spinster, produits d'expression, modele animal non humain: utilisations dans le traitement des troubles metaboliques humains
AR049938A1 (es) 2004-06-25 2006-09-13 Takeda Pharmaceutical Derivados de metastina y utilizacion de los mismos
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
EP2814844B1 (fr) 2012-02-15 2017-08-02 Novo Nordisk A/S Anticorps qui se lient et bloquent la stimulation d'un récepteur exprimé sur des cellules myéloïdes 1 (trem-1)
WO2013120554A1 (fr) 2012-02-15 2013-08-22 Novo Nordisk A/S Anticorps qui se lient à la protéine 1 de reconnaissance de peptidoglycane
WO2014110481A2 (fr) * 2013-01-11 2014-07-17 The Trustees Of Columbia University In The City Of New York Rab7l1 interagit avec lrrk2 pour modifier le tri de protéine intra-neuronale et le risque de maladie de parkinson
BR112016030947A2 (pt) 2014-07-17 2017-10-24 Novo Nordisk As mutagênese dirigida ao local de anticorpos trem-1 para diminuição de viscosidade
JP2021519594A (ja) 2018-04-02 2021-08-12 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 抗ｔｒｅｍ−１抗体およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
CA2153480A1 (fr) * 1993-11-12 1995-06-01 Kenichi Matsubara Signature genique
DK0871702T3 (da) * 1994-12-06 2005-09-19 Immunex Corp Cytokin betegnet Lerk-7
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
DE69634726T2 (de) * 1995-07-19 2006-05-04 Genetics Institute, LLC, Cambridge Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen

Also Published As

Publication number Publication date
WO1998039448A2 (fr) 1998-09-11
WO1998039448A3 (fr) 1998-11-26
WO1998039448A9 (fr) 1998-09-11

Similar Documents

Publication Publication Date Title
CA2283299A1 (fr) 186 nouvelles proteines secretees
Ho et al. Mammalian initiator apoptotic caspases
Barrow et al. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice
Gil et al. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs
US6420526B1 (en) 186 human secreted proteins
US6342581B1 (en) Secreted protein HLHFP03
CA2339301A1 (fr) Acides nucleiques et polypeptides relatifs au hdpbo81
JP6259320B2 (ja) ヒト非小細胞肺癌における転座及び変異体ｒｏｓキナーゼ
US20070154912A1 (en) 87 Human Secreted Proteins
JP2001524814A (ja) ２８種類のヒト分泌タンパク質
CA2399727A1 (fr) Nouveaux homologues de type subtilase (narc-1)
CA2311283A1 (fr) Purification et microsequencage d'isozymes de hyaluronidase
CA2294526A1 (fr) 86 proteines secretees humaines
CA2308768A1 (fr) 125 proteines secretees humaines
CA2372926A1 (fr) 143 proteines humaines secretees
CA2307320A1 (fr) 148 proteines humaines secretees
Lühn et al. Identification and molecular cloning of a functional GDP-fucose transporter in Drosophila melanogaster
US7417124B2 (en) Antibodies specific for phosphorylation sites and screening methods using the same antibodies
CA2298852A1 (fr) 83 proteines humaines secretees
Yin et al. Identification of a novel splice variant of X-linked inhibitor of apoptosis-associated factor 1
AU6158799A (en) Novel cell signaling polypeptides and nucleic acids
KR102458904B1 (ko) 신규의 bmpr2 유전자 기능획득 돌연변이체 및 이의 용도
US20040115682A1 (en) Novel scavenger receptor class a protein
Kovács CHARACTERIZATION OF PEROXIDASIN AND PEROXIDASIN-LIKE PROTEINS IN MAMMALIAN CELLS
Segade et al. Identification of a matrix binding domain in the microfibril-associated glycoproteins 1 and 2 (MAGP1 and 2) and intracellular localization of alternative splice forms

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead